Cambridge Enterprise, University of Cambridge

Cambridge Enterprise, University of Cambridge

Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.

Telephone: +44 (0)1223 760 339
Address: Hauser Forum, 3 Charles Babbage Road, Cambridge
Postcode: CB3 0GT
Country: United Kingdom
Website: http://www.enterprise.cam.ac.uk
Membership type:Cambridge University Department

Cambridge Enterprise offers support to all of the University’s research fields, from science, technology, engineering, maths and medicine to the arts, humanities and social sciences. It is through us that many of the University’s inventions and ideas are protected, licences and consultancy contracts are negotiated, and funding is acquired by start-ups and spin-outs.

heart-arterial-arteries-banner/Cambridge Enterprise

Cambridge spin-out Morphogen-IX announces its clinical development candidate

Morphogen-IX Ltd, a biotechnology spin-out from Cambridge Enterprise that is focused on the development of bone morphogenetic proteins (BMPs) for the treatment of pulmonary arterial hypertension (PAH), announced the nomination of its clinical development candidate and initiation of formal preclinical development.

4 December 2018Read in full

Poro Technologies wins PostDoc Business Plan Competition

Poro Technologies wins the 2018 Postdoc Business Plan Competition

Poro Technologies, which is developing next-generation LED technology, has won the £20,000 first prize in the 2018 Cambridge Enterprise and Entrepreneurial Postdocs of Cambridge (EPOC) Postdoc Business Plan Competition.

6 November 2018Read in full

eye bannner

Astellas announces acquisition of Cambridge spin-out Quethera

Astellas Pharma Inc. and Quethera Limited have announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma.

14 August 2018Read in full

Semi-finalists named in Postdoc Business Plan Competition

Twelve semi-finalists have been named in the 2018 Postdoc Business Plan Competition run by Cambridge Enterprise in conjunction with the Entrepreneurial Postdocs of Cambridge (EPOC).

1 August 2018Read in full

heart_arterial_arteries

Morphogen-IX announces appointment of CEO and SAB members

Morphogen-IX Ltd, a preclinical biotechnology company focused on the development of bone morphogenetic proteins for the treatment of pulmonary arterial hypertension (PAH), has announced the appointment of Professor Nick Morrell as CEO. Morrell co-founded the company in 2015 based on research from his lab at the University of Cambridge.

9 July 2018Read in full

SMG banner

Spin-out Silicon Microgravity secures $7m investment, appoints CEO

Silicon Microgravity (SMG), a spin-out from both BP and the University of Cambridge, has raised $7 million from IP Group, Parkwalk, BP Ventures and Cambridge Enterprise.

12 June 2018Read in full

Microbiotica signs major collaboration with Genentech

Microbiotica, a Cambridge Innovation Capital portfolio company, has entered into a multi-year strategic collaboration with Genentech worth up to $534 million. The companies will work together to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease (IBD).

7 June 2018Read in full

University of Cambridge spin-out Sorex Sensors raises £1.2m

University of Cambridge spin-out Sorex Sensors raises £1.2m

Cambridge Enterprise, the Cambridge Angels and Cambridge Capital Group have completed an initial round of investment in Sorex Sensors Limited, a spin-out company from the Department of Engineering at the University of Cambridge.

4 June 2018Read in full

Cambridge and Shandong University sign agreement

Cambridge and Shandong University sign agreement to support innovation and entrepreneurship

Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, has signed an agreement with one of China’s largest universities to encourage innovation and entrepreneurship in one of China’s fastest-growing high-tech clusters.

1 June 2018Read in full

Global University Venturing charts

Cambridge University spin-outs top list for capital raised, 2013-17; rank 2nd in total deals

An annual data review published by Global University Venturing reports that University of Cambridge spin-outs raised $2,216m in capital for 2013-17, putting it at the top of the global list of universities. The article also reports that in this period Cambridge’s spin-outs closed 96 deals, making it second only to Stanford University in total number of deals, though ahead of it in total capital raised.

29 May 2018Read in full

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. ...
  12. 23
25/10/2018

Ceres Agri-Tech Portfolio Manager/ Director

We are looking for Ceres Agri-Tech Portfolio Manager(s) / Director(s) (depending on experience) to work across the Ceres partner...

Location: Cambridge
Salary: Competitive
More Info